Casa
kurnik login

Factor VIII inhibitors in hemophilia A treated with emicizumab

Por um escritor misterioso

Descrição
Factor VIII inhibitors in hemophilia A treated with emicizumab
Schematic illustrations of the interactions of FVIIIa or
Factor VIII inhibitors in hemophilia A treated with emicizumab
A Molecular Revolution in the Treatment of Hemophilia: Molecular
Factor VIII inhibitors in hemophilia A treated with emicizumab
Emicizumab Prophylaxis in Hemophilia A
Factor VIII inhibitors in hemophilia A treated with emicizumab
Hemlibra® (emicizumab-kxwh) for the Treatment of Haemophilia A
Factor VIII inhibitors in hemophilia A treated with emicizumab
Study protocol for assessment of the coagulation potential of
Factor VIII inhibitors in hemophilia A treated with emicizumab
Inhibitors in haemophilia A and B: Management of bleeds, inhibitor
Factor VIII inhibitors in hemophilia A treated with emicizumab
Novel Insights and New Developments Regarding Coagulation Revealed
Factor VIII inhibitors in hemophilia A treated with emicizumab
Assessment of global coagulation function under treatment with
Factor VIII inhibitors in hemophilia A treated with emicizumab
Development of inhibitors in hemophilia A: An illustrated review
Factor VIII inhibitors in hemophilia A treated with emicizumab
Hemophilia Treatment Market Share Outlook 2022-2028
Factor VIII inhibitors in hemophilia A treated with emicizumab
American Journal of Hematology, Blood Research Journal
Factor VIII inhibitors in hemophilia A treated with emicizumab
Characterizing Emicizumab with Immune Tolerance Induction Therapy
de por adulto (o preço varia de acordo com o tamanho do grupo)